Global Radioisotopes in Medicine Market Growth 2025-2031
The global Radioisotopes in Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2025 through 2031. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out by Type, by Application?
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2025 through 2031. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Tc-99m
- Cobalt-60
- Iodine Radioisotopes
- Others
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NRG
- IRE
- ANSTO
- NTP Radioisotopes
- China National Nuclear Corporation
- Rosatom
- Nordion
- Eckert & Ziegler Strahlen
- Polatom
- SHINE Technologies
- NorthStar Medical Radioisotopes
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioisotopes in Medicine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Radioisotopes in Medicine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Radioisotopes in Medicine by Country/Region, 2020, 2024 & 2031
2.2 Radioisotopes in Medicine Segment by Type
2.2.1 Tc-99m
2.2.2 Cobalt-60
2.2.3 Iodine Radioisotopes
2.2.4 Others
2.3 Radioisotopes in Medicine Sales by Type
2.3.1 Global Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
2.3.2 Global Radioisotopes in Medicine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Radioisotopes in Medicine Sale Price by Type (2020-2025)
2.4 Radioisotopes in Medicine Segment by Application
2.4.1 Nuclear Therapy
2.4.2 Equipment Radioactive Source
2.4.3 Diagnosis
2.5 Radioisotopes in Medicine Sales by Application
2.5.1 Global Radioisotopes in Medicine Sale Market Share by Application (2020-2025)
2.5.2 Global Radioisotopes in Medicine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Radioisotopes in Medicine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Radioisotopes in Medicine Breakdown Data by Company
3.1.1 Global Radioisotopes in Medicine Annual Sales by Company (2020-2025)
3.1.2 Global Radioisotopes in Medicine Sales Market Share by Company (2020-2025)
3.2 Global Radioisotopes in Medicine Annual Revenue by Company (2020-2025)
3.2.1 Global Radioisotopes in Medicine Revenue by Company (2020-2025)
3.2.2 Global Radioisotopes in Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Radioisotopes in Medicine Sale Price by Company
3.4 Key Manufacturers Radioisotopes in Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radioisotopes in Medicine Product Location Distribution
3.4.2 Players Radioisotopes in Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Radioisotopes in Medicine Market Size by Geographic Region (2020-2025)
4.1.1 Global Radioisotopes in Medicine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Radioisotopes in Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Radioisotopes in Medicine Market Size by Country/Region (2020-2025)
4.2.1 Global Radioisotopes in Medicine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Radioisotopes in Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Radioisotopes in Medicine Sales Growth
4.4 APAC Radioisotopes in Medicine Sales Growth
4.5 Europe Radioisotopes in Medicine Sales Growth
4.6 Middle East & Africa Radioisotopes in Medicine Sales Growth
5 AMERICAS
5.1 Americas Radioisotopes in Medicine Sales by Country
5.1.1 Americas Radioisotopes in Medicine Sales by Country (2020-2025)
5.1.2 Americas Radioisotopes in Medicine Revenue by Country (2020-2025)
5.2 Americas Radioisotopes in Medicine Sales by Type (2020-2025)
5.3 Americas Radioisotopes in Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioisotopes in Medicine Sales by Region
6.1.1 APAC Radioisotopes in Medicine Sales by Region (2020-2025)
6.1.2 APAC Radioisotopes in Medicine Revenue by Region (2020-2025)
6.2 APAC Radioisotopes in Medicine Sales by Type (2020-2025)
6.3 APAC Radioisotopes in Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radioisotopes in Medicine by Country
7.1.1 Europe Radioisotopes in Medicine Sales by Country (2020-2025)
7.1.2 Europe Radioisotopes in Medicine Revenue by Country (2020-2025)
7.2 Europe Radioisotopes in Medicine Sales by Type (2020-2025)
7.3 Europe Radioisotopes in Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioisotopes in Medicine by Country
8.1.1 Middle East & Africa Radioisotopes in Medicine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Radioisotopes in Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Radioisotopes in Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Radioisotopes in Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radioisotopes in Medicine
10.3 Manufacturing Process Analysis of Radioisotopes in Medicine
10.4 Industry Chain Structure of Radioisotopes in Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radioisotopes in Medicine Distributors
11.3 Radioisotopes in Medicine Customer
12 WORLD FORECAST REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
12.1 Global Radioisotopes in Medicine Market Size Forecast by Region
12.1.1 Global Radioisotopes in Medicine Forecast by Region (2026-2031)
12.1.2 Global Radioisotopes in Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Radioisotopes in Medicine Forecast by Type (2026-2031)
12.7 Global Radioisotopes in Medicine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NRG
13.1.1 NRG Company Information
13.1.2 NRG Radioisotopes in Medicine Product Portfolios and Specifications
13.1.3 NRG Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NRG Main Business Overview
13.1.5 NRG Latest Developments
13.2 IRE
13.2.1 IRE Company Information
13.2.2 IRE Radioisotopes in Medicine Product Portfolios and Specifications
13.2.3 IRE Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 IRE Main Business Overview
13.2.5 IRE Latest Developments
13.3 ANSTO
13.3.1 ANSTO Company Information
13.3.2 ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
13.3.3 ANSTO Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ANSTO Main Business Overview
13.3.5 ANSTO Latest Developments
13.4 NTP Radioisotopes
13.4.1 NTP Radioisotopes Company Information
13.4.2 NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.4.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 NTP Radioisotopes Main Business Overview
13.4.5 NTP Radioisotopes Latest Developments
13.5 China National Nuclear Corporation
13.5.1 China National Nuclear Corporation Company Information
13.5.2 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
13.5.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 China National Nuclear Corporation Main Business Overview
13.5.5 China National Nuclear Corporation Latest Developments
13.6 Rosatom
13.6.1 Rosatom Company Information
13.6.2 Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
13.6.3 Rosatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Rosatom Main Business Overview
13.6.5 Rosatom Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Radioisotopes in Medicine Product Portfolios and Specifications
13.7.3 Nordion Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eckert & Ziegler Strahlen
13.8.1 Eckert & Ziegler Strahlen Company Information
13.8.2 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
13.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eckert & Ziegler Strahlen Main Business Overview
13.8.5 Eckert & Ziegler Strahlen Latest Developments
13.9 Polatom
13.9.1 Polatom Company Information
13.9.2 Polatom Radioisotopes in Medicine Product Portfolios and Specifications
13.9.3 Polatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Polatom Main Business Overview
13.9.5 Polatom Latest Developments
13.10 SHINE Technologies
13.10.1 SHINE Technologies Company Information
13.10.2 SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
13.10.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SHINE Technologies Main Business Overview
13.10.5 SHINE Technologies Latest Developments
13.11 NorthStar Medical Radioisotopes
13.11.1 NorthStar Medical Radioisotopes Company Information
13.11.2 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 NorthStar Medical Radioisotopes Main Business Overview
13.11.5 NorthStar Medical Radioisotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radioisotopes in Medicine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Radioisotopes in Medicine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Radioisotopes in Medicine by Country/Region, 2020, 2024 & 2031
2.2 Radioisotopes in Medicine Segment by Type
2.2.1 Tc-99m
2.2.2 Cobalt-60
2.2.3 Iodine Radioisotopes
2.2.4 Others
2.3 Radioisotopes in Medicine Sales by Type
2.3.1 Global Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
2.3.2 Global Radioisotopes in Medicine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Radioisotopes in Medicine Sale Price by Type (2020-2025)
2.4 Radioisotopes in Medicine Segment by Application
2.4.1 Nuclear Therapy
2.4.2 Equipment Radioactive Source
2.4.3 Diagnosis
2.5 Radioisotopes in Medicine Sales by Application
2.5.1 Global Radioisotopes in Medicine Sale Market Share by Application (2020-2025)
2.5.2 Global Radioisotopes in Medicine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Radioisotopes in Medicine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Radioisotopes in Medicine Breakdown Data by Company
3.1.1 Global Radioisotopes in Medicine Annual Sales by Company (2020-2025)
3.1.2 Global Radioisotopes in Medicine Sales Market Share by Company (2020-2025)
3.2 Global Radioisotopes in Medicine Annual Revenue by Company (2020-2025)
3.2.1 Global Radioisotopes in Medicine Revenue by Company (2020-2025)
3.2.2 Global Radioisotopes in Medicine Revenue Market Share by Company (2020-2025)
3.3 Global Radioisotopes in Medicine Sale Price by Company
3.4 Key Manufacturers Radioisotopes in Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radioisotopes in Medicine Product Location Distribution
3.4.2 Players Radioisotopes in Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
4.1 World Historic Radioisotopes in Medicine Market Size by Geographic Region (2020-2025)
4.1.1 Global Radioisotopes in Medicine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Radioisotopes in Medicine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Radioisotopes in Medicine Market Size by Country/Region (2020-2025)
4.2.1 Global Radioisotopes in Medicine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Radioisotopes in Medicine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Radioisotopes in Medicine Sales Growth
4.4 APAC Radioisotopes in Medicine Sales Growth
4.5 Europe Radioisotopes in Medicine Sales Growth
4.6 Middle East & Africa Radioisotopes in Medicine Sales Growth
5 AMERICAS
5.1 Americas Radioisotopes in Medicine Sales by Country
5.1.1 Americas Radioisotopes in Medicine Sales by Country (2020-2025)
5.1.2 Americas Radioisotopes in Medicine Revenue by Country (2020-2025)
5.2 Americas Radioisotopes in Medicine Sales by Type (2020-2025)
5.3 Americas Radioisotopes in Medicine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radioisotopes in Medicine Sales by Region
6.1.1 APAC Radioisotopes in Medicine Sales by Region (2020-2025)
6.1.2 APAC Radioisotopes in Medicine Revenue by Region (2020-2025)
6.2 APAC Radioisotopes in Medicine Sales by Type (2020-2025)
6.3 APAC Radioisotopes in Medicine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radioisotopes in Medicine by Country
7.1.1 Europe Radioisotopes in Medicine Sales by Country (2020-2025)
7.1.2 Europe Radioisotopes in Medicine Revenue by Country (2020-2025)
7.2 Europe Radioisotopes in Medicine Sales by Type (2020-2025)
7.3 Europe Radioisotopes in Medicine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radioisotopes in Medicine by Country
8.1.1 Middle East & Africa Radioisotopes in Medicine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Radioisotopes in Medicine Revenue by Country (2020-2025)
8.2 Middle East & Africa Radioisotopes in Medicine Sales by Type (2020-2025)
8.3 Middle East & Africa Radioisotopes in Medicine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radioisotopes in Medicine
10.3 Manufacturing Process Analysis of Radioisotopes in Medicine
10.4 Industry Chain Structure of Radioisotopes in Medicine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radioisotopes in Medicine Distributors
11.3 Radioisotopes in Medicine Customer
12 WORLD FORECAST REVIEW FOR RADIOISOTOPES IN MEDICINE BY GEOGRAPHIC REGION
12.1 Global Radioisotopes in Medicine Market Size Forecast by Region
12.1.1 Global Radioisotopes in Medicine Forecast by Region (2026-2031)
12.1.2 Global Radioisotopes in Medicine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Radioisotopes in Medicine Forecast by Type (2026-2031)
12.7 Global Radioisotopes in Medicine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 NRG
13.1.1 NRG Company Information
13.1.2 NRG Radioisotopes in Medicine Product Portfolios and Specifications
13.1.3 NRG Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 NRG Main Business Overview
13.1.5 NRG Latest Developments
13.2 IRE
13.2.1 IRE Company Information
13.2.2 IRE Radioisotopes in Medicine Product Portfolios and Specifications
13.2.3 IRE Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 IRE Main Business Overview
13.2.5 IRE Latest Developments
13.3 ANSTO
13.3.1 ANSTO Company Information
13.3.2 ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
13.3.3 ANSTO Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ANSTO Main Business Overview
13.3.5 ANSTO Latest Developments
13.4 NTP Radioisotopes
13.4.1 NTP Radioisotopes Company Information
13.4.2 NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.4.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 NTP Radioisotopes Main Business Overview
13.4.5 NTP Radioisotopes Latest Developments
13.5 China National Nuclear Corporation
13.5.1 China National Nuclear Corporation Company Information
13.5.2 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
13.5.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 China National Nuclear Corporation Main Business Overview
13.5.5 China National Nuclear Corporation Latest Developments
13.6 Rosatom
13.6.1 Rosatom Company Information
13.6.2 Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
13.6.3 Rosatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Rosatom Main Business Overview
13.6.5 Rosatom Latest Developments
13.7 Nordion
13.7.1 Nordion Company Information
13.7.2 Nordion Radioisotopes in Medicine Product Portfolios and Specifications
13.7.3 Nordion Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nordion Main Business Overview
13.7.5 Nordion Latest Developments
13.8 Eckert & Ziegler Strahlen
13.8.1 Eckert & Ziegler Strahlen Company Information
13.8.2 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
13.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Eckert & Ziegler Strahlen Main Business Overview
13.8.5 Eckert & Ziegler Strahlen Latest Developments
13.9 Polatom
13.9.1 Polatom Company Information
13.9.2 Polatom Radioisotopes in Medicine Product Portfolios and Specifications
13.9.3 Polatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Polatom Main Business Overview
13.9.5 Polatom Latest Developments
13.10 SHINE Technologies
13.10.1 SHINE Technologies Company Information
13.10.2 SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
13.10.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 SHINE Technologies Main Business Overview
13.10.5 SHINE Technologies Latest Developments
13.11 NorthStar Medical Radioisotopes
13.11.1 NorthStar Medical Radioisotopes Company Information
13.11.2 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
13.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 NorthStar Medical Radioisotopes Main Business Overview
13.11.5 NorthStar Medical Radioisotopes Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radioisotopes in Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Radioisotopes in Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of Cobalt-60
Table 5. Major Players of Iodine Radioisotopes
Table 6. Major Players of Others
Table 7. Global Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 8. Global Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Table 9. Global Radioisotopes in Medicine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Radioisotopes in Medicine Revenue Market Share by Type (2020-2025)
Table 11. Global Radioisotopes in Medicine Sale Price by Type (2020-2025) & (US$/Curie)
Table 12. Global Radioisotopes in Medicine Sale by Application (2020-2025) & (K Curie)
Table 13. Global Radioisotopes in Medicine Sale Market Share by Application (2020-2025)
Table 14. Global Radioisotopes in Medicine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Radioisotopes in Medicine Revenue Market Share by Application (2020-2025)
Table 16. Global Radioisotopes in Medicine Sale Price by Application (2020-2025) & (US$/Curie)
Table 17. Global Radioisotopes in Medicine Sales by Company (2020-2025) & (K Curie)
Table 18. Global Radioisotopes in Medicine Sales Market Share by Company (2020-2025)
Table 19. Global Radioisotopes in Medicine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Radioisotopes in Medicine Revenue Market Share by Company (2020-2025)
Table 21. Global Radioisotopes in Medicine Sale Price by Company (2020-2025) & (US$/Curie)
Table 22. Key Manufacturers Radioisotopes in Medicine Producing Area Distribution and Sales Area
Table 23. Players Radioisotopes in Medicine Products Offered
Table 24. Radioisotopes in Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Radioisotopes in Medicine Sales by Geographic Region (2020-2025) & (K Curie)
Table 28. Global Radioisotopes in Medicine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Radioisotopes in Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Radioisotopes in Medicine Sales by Country/Region (2020-2025) & (K Curie)
Table 32. Global Radioisotopes in Medicine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Radioisotopes in Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Radioisotopes in Medicine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 36. Americas Radioisotopes in Medicine Sales Market Share by Country (2020-2025)
Table 37. Americas Radioisotopes in Medicine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 39. Americas Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 40. APAC Radioisotopes in Medicine Sales by Region (2020-2025) & (K Curie)
Table 41. APAC Radioisotopes in Medicine Sales Market Share by Region (2020-2025)
Table 42. APAC Radioisotopes in Medicine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 44. APAC Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 45. Europe Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 46. Europe Radioisotopes in Medicine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 48. Europe Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 49. Middle East & Africa Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 50. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 52. Middle East & Africa Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 53. Key Market Drivers & Growth Opportunities of Radioisotopes in Medicine
Table 54. Key Market Challenges & Risks of Radioisotopes in Medicine
Table 55. Key Industry Trends of Radioisotopes in Medicine
Table 56. Radioisotopes in Medicine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Radioisotopes in Medicine Distributors List
Table 59. Radioisotopes in Medicine Customer List
Table 60. Global Radioisotopes in Medicine Sales Forecast by Region (2026-2031) & (K Curie)
Table 61. Global Radioisotopes in Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 63. Americas Radioisotopes in Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Radioisotopes in Medicine Sales Forecast by Region (2026-2031) & (K Curie)
Table 65. APAC Radioisotopes in Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 67. Europe Radioisotopes in Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 69. Middle East & Africa Radioisotopes in Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Radioisotopes in Medicine Sales Forecast by Type (2026-2031) & (K Curie)
Table 71. Global Radioisotopes in Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Radioisotopes in Medicine Sales Forecast by Application (2026-2031) & (K Curie)
Table 73. Global Radioisotopes in Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. NRG Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 75. NRG Radioisotopes in Medicine Product Portfolios and Specifications
Table 76. NRG Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 77. NRG Main Business
Table 78. NRG Latest Developments
Table 79. IRE Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. IRE Radioisotopes in Medicine Product Portfolios and Specifications
Table 81. IRE Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 82. IRE Main Business
Table 83. IRE Latest Developments
Table 84. ANSTO Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
Table 86. ANSTO Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 87. ANSTO Main Business
Table 88. ANSTO Latest Developments
Table 89. NTP Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 91. NTP Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 92. NTP Radioisotopes Main Business
Table 93. NTP Radioisotopes Latest Developments
Table 94. China National Nuclear Corporation Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
Table 96. China National Nuclear Corporation Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 97. China National Nuclear Corporation Main Business
Table 98. China National Nuclear Corporation Latest Developments
Table 99. Rosatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 101. Rosatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 102. Rosatom Main Business
Table 103. Rosatom Latest Developments
Table 104. Nordion Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Nordion Radioisotopes in Medicine Product Portfolios and Specifications
Table 106. Nordion Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 107. Nordion Main Business
Table 108. Nordion Latest Developments
Table 109. Eckert & Ziegler Strahlen Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
Table 111. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 112. Eckert & Ziegler Strahlen Main Business
Table 113. Eckert & Ziegler Strahlen Latest Developments
Table 114. Polatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. Polatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 116. Polatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 117. Polatom Main Business
Table 118. Polatom Latest Developments
Table 119. SHINE Technologies Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
Table 121. SHINE Technologies Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 122. SHINE Technologies Main Business
Table 123. SHINE Technologies Latest Developments
Table 124. NorthStar Medical Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 126. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 127. NorthStar Medical Radioisotopes Main Business
Table 128. NorthStar Medical Radioisotopes Latest Developments
Table 1. Radioisotopes in Medicine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Radioisotopes in Medicine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tc-99m
Table 4. Major Players of Cobalt-60
Table 5. Major Players of Iodine Radioisotopes
Table 6. Major Players of Others
Table 7. Global Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 8. Global Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Table 9. Global Radioisotopes in Medicine Revenue by Type (2020-2025) & ($ million)
Table 10. Global Radioisotopes in Medicine Revenue Market Share by Type (2020-2025)
Table 11. Global Radioisotopes in Medicine Sale Price by Type (2020-2025) & (US$/Curie)
Table 12. Global Radioisotopes in Medicine Sale by Application (2020-2025) & (K Curie)
Table 13. Global Radioisotopes in Medicine Sale Market Share by Application (2020-2025)
Table 14. Global Radioisotopes in Medicine Revenue by Application (2020-2025) & ($ million)
Table 15. Global Radioisotopes in Medicine Revenue Market Share by Application (2020-2025)
Table 16. Global Radioisotopes in Medicine Sale Price by Application (2020-2025) & (US$/Curie)
Table 17. Global Radioisotopes in Medicine Sales by Company (2020-2025) & (K Curie)
Table 18. Global Radioisotopes in Medicine Sales Market Share by Company (2020-2025)
Table 19. Global Radioisotopes in Medicine Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Radioisotopes in Medicine Revenue Market Share by Company (2020-2025)
Table 21. Global Radioisotopes in Medicine Sale Price by Company (2020-2025) & (US$/Curie)
Table 22. Key Manufacturers Radioisotopes in Medicine Producing Area Distribution and Sales Area
Table 23. Players Radioisotopes in Medicine Products Offered
Table 24. Radioisotopes in Medicine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Radioisotopes in Medicine Sales by Geographic Region (2020-2025) & (K Curie)
Table 28. Global Radioisotopes in Medicine Sales Market Share Geographic Region (2020-2025)
Table 29. Global Radioisotopes in Medicine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Radioisotopes in Medicine Sales by Country/Region (2020-2025) & (K Curie)
Table 32. Global Radioisotopes in Medicine Sales Market Share by Country/Region (2020-2025)
Table 33. Global Radioisotopes in Medicine Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Radioisotopes in Medicine Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 36. Americas Radioisotopes in Medicine Sales Market Share by Country (2020-2025)
Table 37. Americas Radioisotopes in Medicine Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 39. Americas Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 40. APAC Radioisotopes in Medicine Sales by Region (2020-2025) & (K Curie)
Table 41. APAC Radioisotopes in Medicine Sales Market Share by Region (2020-2025)
Table 42. APAC Radioisotopes in Medicine Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 44. APAC Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 45. Europe Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 46. Europe Radioisotopes in Medicine Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 48. Europe Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 49. Middle East & Africa Radioisotopes in Medicine Sales by Country (2020-2025) & (K Curie)
Table 50. Middle East & Africa Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Radioisotopes in Medicine Sales by Type (2020-2025) & (K Curie)
Table 52. Middle East & Africa Radioisotopes in Medicine Sales by Application (2020-2025) & (K Curie)
Table 53. Key Market Drivers & Growth Opportunities of Radioisotopes in Medicine
Table 54. Key Market Challenges & Risks of Radioisotopes in Medicine
Table 55. Key Industry Trends of Radioisotopes in Medicine
Table 56. Radioisotopes in Medicine Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Radioisotopes in Medicine Distributors List
Table 59. Radioisotopes in Medicine Customer List
Table 60. Global Radioisotopes in Medicine Sales Forecast by Region (2026-2031) & (K Curie)
Table 61. Global Radioisotopes in Medicine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 63. Americas Radioisotopes in Medicine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Radioisotopes in Medicine Sales Forecast by Region (2026-2031) & (K Curie)
Table 65. APAC Radioisotopes in Medicine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 67. Europe Radioisotopes in Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Radioisotopes in Medicine Sales Forecast by Country (2026-2031) & (K Curie)
Table 69. Middle East & Africa Radioisotopes in Medicine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Radioisotopes in Medicine Sales Forecast by Type (2026-2031) & (K Curie)
Table 71. Global Radioisotopes in Medicine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Radioisotopes in Medicine Sales Forecast by Application (2026-2031) & (K Curie)
Table 73. Global Radioisotopes in Medicine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. NRG Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 75. NRG Radioisotopes in Medicine Product Portfolios and Specifications
Table 76. NRG Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 77. NRG Main Business
Table 78. NRG Latest Developments
Table 79. IRE Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. IRE Radioisotopes in Medicine Product Portfolios and Specifications
Table 81. IRE Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 82. IRE Main Business
Table 83. IRE Latest Developments
Table 84. ANSTO Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. ANSTO Radioisotopes in Medicine Product Portfolios and Specifications
Table 86. ANSTO Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 87. ANSTO Main Business
Table 88. ANSTO Latest Developments
Table 89. NTP Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. NTP Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 91. NTP Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 92. NTP Radioisotopes Main Business
Table 93. NTP Radioisotopes Latest Developments
Table 94. China National Nuclear Corporation Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolios and Specifications
Table 96. China National Nuclear Corporation Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 97. China National Nuclear Corporation Main Business
Table 98. China National Nuclear Corporation Latest Developments
Table 99. Rosatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Rosatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 101. Rosatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 102. Rosatom Main Business
Table 103. Rosatom Latest Developments
Table 104. Nordion Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Nordion Radioisotopes in Medicine Product Portfolios and Specifications
Table 106. Nordion Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 107. Nordion Main Business
Table 108. Nordion Latest Developments
Table 109. Eckert & Ziegler Strahlen Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolios and Specifications
Table 111. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 112. Eckert & Ziegler Strahlen Main Business
Table 113. Eckert & Ziegler Strahlen Latest Developments
Table 114. Polatom Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. Polatom Radioisotopes in Medicine Product Portfolios and Specifications
Table 116. Polatom Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 117. Polatom Main Business
Table 118. Polatom Latest Developments
Table 119. SHINE Technologies Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. SHINE Technologies Radioisotopes in Medicine Product Portfolios and Specifications
Table 121. SHINE Technologies Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 122. SHINE Technologies Main Business
Table 123. SHINE Technologies Latest Developments
Table 124. NorthStar Medical Radioisotopes Basic Information, Radioisotopes in Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolios and Specifications
Table 126. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (K Curie), Revenue ($ Million), Price (US$/Curie) and Gross Margin (2020-2025)
Table 127. NorthStar Medical Radioisotopes Main Business
Table 128. NorthStar Medical Radioisotopes Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radioisotopes in Medicine
Figure 2. Radioisotopes in Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radioisotopes in Medicine Sales Growth Rate 2020-2031 (K Curie)
Figure 7. Global Radioisotopes in Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Radioisotopes in Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Radioisotopes in Medicine Sales Market Share by Country/Region (2024)
Figure 10. Radioisotopes in Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tc-99m
Figure 12. Product Picture of Cobalt-60
Figure 13. Product Picture of Iodine Radioisotopes
Figure 14. Product Picture of Others
Figure 15. Global Radioisotopes in Medicine Sales Market Share by Type in 2025
Figure 16. Global Radioisotopes in Medicine Revenue Market Share by Type (2020-2025)
Figure 17. Radioisotopes in Medicine Consumed in Nuclear Therapy
Figure 18. Global Radioisotopes in Medicine Market: Nuclear Therapy (2020-2025) & (K Curie)
Figure 19. Radioisotopes in Medicine Consumed in Equipment Radioactive Source
Figure 20. Global Radioisotopes in Medicine Market: Equipment Radioactive Source (2020-2025) & (K Curie)
Figure 21. Radioisotopes in Medicine Consumed in Diagnosis
Figure 22. Global Radioisotopes in Medicine Market: Diagnosis (2020-2025) & (K Curie)
Figure 23. Global Radioisotopes in Medicine Sale Market Share by Application (2024)
Figure 24. Global Radioisotopes in Medicine Revenue Market Share by Application in 2025
Figure 25. Radioisotopes in Medicine Sales by Company in 2025 (K Curie)
Figure 26. Global Radioisotopes in Medicine Sales Market Share by Company in 2025
Figure 27. Radioisotopes in Medicine Revenue by Company in 2025 ($ millions)
Figure 28. Global Radioisotopes in Medicine Revenue Market Share by Company in 2025
Figure 29. Global Radioisotopes in Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 32. Americas Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 33. APAC Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 34. APAC Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 35. Europe Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 36. Europe Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 38. Middle East & Africa Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 39. Americas Radioisotopes in Medicine Sales Market Share by Country in 2025
Figure 40. Americas Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Figure 41. Americas Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 42. Americas Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 43. United States Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Radioisotopes in Medicine Sales Market Share by Region in 2025
Figure 48. APAC Radioisotopes in Medicine Revenue Market Share by Region (2020-2025)
Figure 49. APAC Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 50. APAC Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 51. China Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. India Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Radioisotopes in Medicine Sales Market Share by Country in 2025
Figure 59. Europe Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Figure 60. Europe Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 61. Europe Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 62. Germany Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 63. France Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 70. Egypt Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Radioisotopes in Medicine in 2025
Figure 76. Manufacturing Process Analysis of Radioisotopes in Medicine
Figure 77. Industry Chain Structure of Radioisotopes in Medicine
Figure 78. Channels of Distribution
Figure 79. Global Radioisotopes in Medicine Sales Market Forecast by Region (2026-2031)
Figure 80. Global Radioisotopes in Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Radioisotopes in Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Radioisotopes in Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Radioisotopes in Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Radioisotopes in Medicine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Radioisotopes in Medicine
Figure 2. Radioisotopes in Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radioisotopes in Medicine Sales Growth Rate 2020-2031 (K Curie)
Figure 7. Global Radioisotopes in Medicine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Radioisotopes in Medicine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Radioisotopes in Medicine Sales Market Share by Country/Region (2024)
Figure 10. Radioisotopes in Medicine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tc-99m
Figure 12. Product Picture of Cobalt-60
Figure 13. Product Picture of Iodine Radioisotopes
Figure 14. Product Picture of Others
Figure 15. Global Radioisotopes in Medicine Sales Market Share by Type in 2025
Figure 16. Global Radioisotopes in Medicine Revenue Market Share by Type (2020-2025)
Figure 17. Radioisotopes in Medicine Consumed in Nuclear Therapy
Figure 18. Global Radioisotopes in Medicine Market: Nuclear Therapy (2020-2025) & (K Curie)
Figure 19. Radioisotopes in Medicine Consumed in Equipment Radioactive Source
Figure 20. Global Radioisotopes in Medicine Market: Equipment Radioactive Source (2020-2025) & (K Curie)
Figure 21. Radioisotopes in Medicine Consumed in Diagnosis
Figure 22. Global Radioisotopes in Medicine Market: Diagnosis (2020-2025) & (K Curie)
Figure 23. Global Radioisotopes in Medicine Sale Market Share by Application (2024)
Figure 24. Global Radioisotopes in Medicine Revenue Market Share by Application in 2025
Figure 25. Radioisotopes in Medicine Sales by Company in 2025 (K Curie)
Figure 26. Global Radioisotopes in Medicine Sales Market Share by Company in 2025
Figure 27. Radioisotopes in Medicine Revenue by Company in 2025 ($ millions)
Figure 28. Global Radioisotopes in Medicine Revenue Market Share by Company in 2025
Figure 29. Global Radioisotopes in Medicine Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Radioisotopes in Medicine Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 32. Americas Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 33. APAC Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 34. APAC Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 35. Europe Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 36. Europe Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Radioisotopes in Medicine Sales 2020-2025 (K Curie)
Figure 38. Middle East & Africa Radioisotopes in Medicine Revenue 2020-2025 ($ millions)
Figure 39. Americas Radioisotopes in Medicine Sales Market Share by Country in 2025
Figure 40. Americas Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Figure 41. Americas Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 42. Americas Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 43. United States Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Radioisotopes in Medicine Sales Market Share by Region in 2025
Figure 48. APAC Radioisotopes in Medicine Revenue Market Share by Region (2020-2025)
Figure 49. APAC Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 50. APAC Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 51. China Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 55. India Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Radioisotopes in Medicine Sales Market Share by Country in 2025
Figure 59. Europe Radioisotopes in Medicine Revenue Market Share by Country (2020-2025)
Figure 60. Europe Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 61. Europe Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 62. Germany Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 63. France Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Radioisotopes in Medicine Sales Market Share by Application (2020-2025)
Figure 70. Egypt Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Radioisotopes in Medicine Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Radioisotopes in Medicine in 2025
Figure 76. Manufacturing Process Analysis of Radioisotopes in Medicine
Figure 77. Industry Chain Structure of Radioisotopes in Medicine
Figure 78. Channels of Distribution
Figure 79. Global Radioisotopes in Medicine Sales Market Forecast by Region (2026-2031)
Figure 80. Global Radioisotopes in Medicine Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Radioisotopes in Medicine Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Radioisotopes in Medicine Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Radioisotopes in Medicine Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Radioisotopes in Medicine Revenue Market Share Forecast by Application (2026-2031)
